Holen Sie sich die Stockscreener-App
335.43
3.08%
-10.67
Vorhandelsmarkt:
321.50
-13.93
-4.15%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LRCX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$346.10
Offen:
$357.25
24-Stunden-Volumen:
10.24M
Relative Volume:
0.94
Marktkapitalisierung:
$419.48B
Einnahmen:
$21.68B
Nettoeinkommen (Verlust:
$6.71B
KGV:
63.31
EPS:
5.298
Netto-Cashflow:
$6.00B
1W Leistung:
+0.68%
1M Leistung:
-13.75%
6M Leistung:
+54.24%
1J Leistung:
+231.88%
1-Tages-Spanne:
$319.79
$357.25
1-Wochen-Bereich:
$319.79
$369.95
52-Wochen-Spanne:
$90.73
$438.50
Lam Research Corp Stock (LRCX) Company Profile
Firmenname
Lam Research Corp
Sektor
Telefon
(510) 659-0200
Adresse
4650 CUSHING BLVD, FREMONT, CA
Compare LRCX vs ASML, AMAT, KLAC, TER
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LRCX
Lam Research Corp
|
335.43 | 412.59B | 21.68B | 6.71B | 6.00B | 5.298 |
ASML
Asml Holding Nv
|
1,815.27 | 665.25B | 39.08B | 11.61B | 9.94B | 30.00 |
AMAT
Applied Materials Inc
|
579.43 | 456.84B | 29.02B | 8.51B | 5.34B | 10.64 |
KLAC
Kla Corp
|
224.50 | 290.32B | 13.09B | 4.67B | 4.01B | 35.37 |
TER
Teradyne Inc
|
342.12 | 53.40B | 3.79B | 854.06M | 553.18M | 5.4031 |
Lam Research Corp Stock (LRCX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-02 | Herabstufung | Erste Group | Buy → Hold |
| 2026-01-29 | Hochstufung | Summit Insights | Hold → Buy |
| 2026-01-29 | Bestätigt | TD Cowen | Buy |
| 2026-01-15 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2026-01-15 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-10-23 | Bestätigt | TD Cowen | Buy |
| 2025-09-30 | Eingeleitet | HSBC Securities | Hold |
| 2025-09-29 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2025-09-23 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-09-22 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2025-09-02 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2025-08-14 | Fortgesetzt | Erste Group | Buy |
| 2025-07-31 | Herabstufung | Summit Insights | Buy → Hold |
| 2025-07-31 | Bestätigt | TD Cowen | Buy |
| 2025-07-10 | Eingeleitet | Goldman | Buy |
| 2025-04-24 | Bestätigt | TD Cowen | Buy |
| 2025-03-20 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-02-20 | Hochstufung | Susquehanna | Neutral → Positive |
| 2025-01-30 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2025-01-30 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-17 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-01-15 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-12-17 | Eingeleitet | Cleveland Research | Neutral |
| 2024-08-01 | Bestätigt | TD Cowen | Buy |
| 2024-05-13 | Eingeleitet | Jefferies | Buy |
| 2024-04-25 | Bestätigt | TD Cowen | Buy |
| 2024-04-19 | Hochstufung | B. Riley Securities | Neutral → Buy |
| 2024-04-18 | Bestätigt | Needham | Buy |
| 2024-04-16 | Eingeleitet | Evercore ISI | Outperform |
| 2024-04-11 | Fortgesetzt | Deutsche Bank | Hold |
| 2024-01-25 | Bestätigt | TD Cowen | Outperform |
| 2024-01-23 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2023-12-12 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-12-08 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-11-22 | Eingeleitet | Redburn Atlantic | Buy |
| 2023-10-17 | Eingeleitet | Raymond James | Outperform |
| 2023-10-13 | Hochstufung | Needham | Hold → Buy |
| 2023-09-15 | Eingeleitet | Wolfe Research | Outperform |
| 2023-07-24 | Bestätigt | Mizuho | Buy |
| 2023-07-24 | Hochstufung | Stifel | Hold → Buy |
| 2023-04-20 | Bestätigt | Berenberg | Buy |
| 2023-04-20 | Bestätigt | Evercore ISI | Outperform |
| 2023-04-20 | Bestätigt | JP Morgan | Overweight |
| 2023-04-20 | Bestätigt | Jefferies | Buy |
| 2023-04-20 | Bestätigt | Mizuho | Buy |
| 2023-04-20 | Bestätigt | Stifel | Hold |
| 2023-04-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2023-03-13 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-01-18 | Fortgesetzt | Stifel | Hold |
| 2022-12-12 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-10-20 | Bestätigt | B. Riley Securities | Neutral |
| 2022-10-20 | Bestätigt | BofA Securities | Buy |
| 2022-10-20 | Bestätigt | DA Davidson | Neutral |
| 2022-10-20 | Bestätigt | Evercore ISI | Outperform |
| 2022-10-20 | Bestätigt | JP Morgan | Overweight |
| 2022-10-20 | Bestätigt | Jefferies | Buy |
| 2022-10-20 | Hochstufung | Summit Insights | Hold → Buy |
| 2022-10-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2022-07-25 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-06-15 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2022-01-27 | Bestätigt | Barclays | Overweight |
| 2022-01-27 | Bestätigt | Deutsche Bank | Hold |
| 2022-01-27 | Bestätigt | Evercore ISI | Outperform |
| 2022-01-27 | Bestätigt | Stifel | Buy |
| 2022-01-27 | Bestätigt | Susquehanna | Neutral |
| 2022-01-27 | Bestätigt | UBS | Buy |
| 2022-01-26 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-01-12 | Bestätigt | Barclays | Overweight |
| 2022-01-10 | Bestätigt | BofA Securities | Buy |
| 2022-01-05 | Fortgesetzt | Jefferies | Buy |
| 2021-12-15 | Bestätigt | Deutsche Bank | Hold |
| 2021-10-21 | Bestätigt | B. Riley Securities | Buy |
| 2021-10-21 | Herabstufung | Summit Insights | Buy → Hold |
| 2021-10-15 | Eingeleitet | Piper Sandler | Neutral |
| 2021-09-14 | Herabstufung | Susquehanna | Positive → Neutral |
| 2021-09-07 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2021-07-29 | Bestätigt | Mizuho | Buy |
| 2021-07-29 | Bestätigt | Stifel | Buy |
| 2021-07-29 | Bestätigt | UBS | Buy |
| 2021-07-29 | Bestätigt | Wells Fargo | Equal Weight |
| 2021-03-31 | Eingeleitet | Bernstein | Outperform |
| 2021-01-28 | Bestätigt | Cowen | Outperform |
| 2021-01-08 | Herabstufung | Needham | Buy → Hold |
| 2020-12-17 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2020-10-22 | Bestätigt | Goldman | Buy |
| 2020-10-22 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2020-10-22 | Bestätigt | Mizuho | Buy |
| 2020-10-22 | Bestätigt | Morgan Stanley | Overweight |
| 2020-10-22 | Bestätigt | RBC Capital Mkts | Outperform |
| 2020-10-22 | Bestätigt | Stifel | Buy |
| 2020-10-22 | Bestätigt | UBS | Buy |
| 2020-09-21 | Hochstufung | Stifel | Hold → Buy |
| 2020-07-30 | Bestätigt | Cowen | Outperform |
| 2020-07-21 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2020-06-22 | Herabstufung | Stifel | Buy → Hold |
| 2020-06-16 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-05-26 | Eingeleitet | Barclays | Overweight |
| 2020-04-23 | Bestätigt | Needham | Buy |
| 2020-04-08 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2020-04-03 | Hochstufung | Nomura | Neutral → Buy |
| 2020-04-02 | Herabstufung | DA Davidson | Buy → Neutral |
| 2020-03-27 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-03-27 | Hochstufung | UBS | Sell → Buy |
Alle ansehen
Lam Research Corp Aktie (LRCX) Neueste Nachrichten
Twin Capital Management Inc. Purchases 8,407 Shares of Lam Research Corporation $LRCX - MarketBeat
Sigma Planning Corp Sells 4,260 Shares of Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation $LRCX Position Lessened by Bank of New York Mellon Corp - MarketBeat
Lam Research Corp (1LRCX) Q4 2025 Earnings ReportResults, Call & Slides - TipRanks
Lam Research Corp (1LRCX) Q1 2025 Earnings ReportResults, Call & Slides - TipRanks
Lam Research Corp (1LRCX) Q2 2025 Earnings ReportResults, Call & Slides - TipRanks
Book value per share of Lam Research Corp Shs Thailand Depositary Receipts Repr 1 Sh – SET:LRCX80 - TradingView
Lam Research Corp. stock outperforms competitors despite losses on the day - MarketWatch
Lam Research Corp Stock (LRCX) Moved Down by 6.34% on Jul 15: A Full Analysis - TradingKey
UBS Raises Lam Research Price Target to $435 From $375, Maintains Buy Rating - Moomoo
Lam Research Corp (LRCX:CT): Stock Price, Quote and News - BNN Bloomberg
Is Lam Research Corp (LRCX) Overvalued After 4.9% Rally? GF Valu - GuruFocus
Lam Research Rises as Chip-Equipment Sentiment Improves Ahead of Earnings - Quiver Quantitative
Form 4 Lam Research Corp For: 14 July By Investing.com - Investing.com South Africa
Goldman Sachs, Lam Research among market cap stock movers on Tuesday - Investing.com Nigeria
Lam Research director Abhijit Talwalkar sells $6.1m in company stock - Investing.com
Lam Research director Abhijit Talwalkar sells $6.1m in company stock By Investing.com - Investing.com India
Lam Research (NASDAQ:LRCX) Director Sells $6,124,470.00 in Stock - MarketBeat
Lam Research Insider Sold Shares Worth $6,124,470, According to a Recent SEC Filing - Moomoo
Lam Research Corp (LRCX) director sells 18,282 shares under 10b5-1 plan - Stock Titan
Had You Bought This Magnificent Vanguard ETF at the Start of January, You'd Be Crushing the S&P 500 in 2026 - The Motley Fool
Lam Research Corp Stock (LRCX) Moved Up by 4.24% on Jul 14: What Investors Need To Know - TradingKey
Lam Research stock holds steady as equipment demand underpins long-term growth - Ad-hoc-news.de
US512807AU2 Bond Profile — Key Metrics - TradingView
LARD Bond Profile — Key Metrics - TradingView
Lam Research Corp. stock underperforms Monday when compared to competitors - MSN
Lam Research Corporation's Stock Price Drops to $329.92, Marking a 5.83% Decrease: Is It Time to Buy? - Smartkarma
US512807AV0 Bond Profile — Key Metrics - TradingView
Lam Research Corp (LRCX) Shares Fall 5.8% -- What GF Score of 85 Tells Investors - GuruFocus
Lam Research stock reflects steady chip-equipment demand as investors weigh memory recovery - Ad Hoc News
Form 144 LAM RESEARCH CORP For: 13 July By Investing.com - Investing.com Nigeria
Lam Research Corp Stock (LRCX) Moved Down by 5.28% on Jul 13: What Investors Need To Know - TradingKey
Holder plans Rule 144 sale of LRCX (LRCX) shares worth $6.1M - Stock Titan
Lam Research stock reflects chip equipment demand amid cyclical recovery - ad-hoc-news.de
Lam Research stock reflects steady position in the chip equipment cycle - ad-hoc-news.de
Signature Resources Capital Management LLC Lowers Stock Position in Lam Research Corporation $LRCX - MarketBeat
Cullinan Associates Inc. Takes Position in Lam Research Corporation $LRCX - MarketBeat
Associated Banc Corp Sells 175,971 Shares of Lam Research Corporation $LRCX - MarketBeat
Lam Research stock reflects steady semiconductor demand - ad-hoc-news.de
Lam Research: Wouldn't Be Surprised If Consolidation Is Next (Rating Downgrade) - Seeking Alpha
Transamerica Multi-Managed Balanced's Lam Research Corp(LRCX) Holding History - GuruFocus
Aehr Test Systems, Lam Research, Applied Materials And Other Big Stocks Moving Higher On Thursday - Sahm
Lam Research Is Maintained at Buy by Needham - Moomoo
Stifel Adjusts Price Target on Lam Research to $425 From $325 - Moomoo
Lam Research Corp. stock underperforms Monday when compared to competitors despite daily gains - MSN
Lam Research Corp. stock outperforms competitors on strong trading day - MSN
TD Cowen Adjusts Price Target on Lam Research to $400 From $340 - Moomoo
Lam Research Price Target Raised to $400.00/Share From $340.00 by TD Cowen - Moomoo
Is Lam Research Corp (LRCX) Overvalued After 6.0% Rally? GF Valu - GuruFocus
Mizuho raises Lam Research stock price target on AI chip demand By Investing.com - Investing.com Australia
Applied Materials and Lam Research Take Off on Meta’s Chip Plans - Barron's
Finanzdaten der Lam Research Corp-Aktie (LRCX)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.73%
2.23%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):